SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Qatar, Ireland accuse Israel of using chemical weapons on Palestinians, demand watchdog probe use - 2Turkiye’s Erdogan calls Israel’s Somaliland recognition ‘unacceptable’
- 3Relentless rise in carbon pollution from fossil fuels slightly dampens climate-fighting hopes
- 4How AI fixed the James Webb Space Telescope's blurry vision
- 5Clovis Unified students spend spring break traveling through China
- 6 Fun Urban areas For Seniors To Travel
- International issues on the agenda as Frances's Macron visits China
- Day to day Temporary Positions That Compensate Fairly in the US
- Tatiana Schlossberg, a granddaughter of JFK, is dead at 35 after cancer diagnosis
- Yes, NASA's launching Artemis 2 astronauts to the moon on April Fools' Day. It's not a joke.
- 25 Most Beautiful Villages in France You Can Actually Visit
- Germany raises prospect of military forces to secure Ukraine peace
- Photos: Hundreds Gather at Bondi Beach After Deadly Attack
- The Best Internet based Retailers for Style and Frill
